99 related articles for article (PubMed ID: 100468)
1. Pathogenesis of experimental Pseudomonas keratitis in the guinea pig: bacteriologic, clinical, and microscopic observations.
Van Horn DL; Davis SD; Hyndiuk RA; Alpren TV
Invest Ophthalmol Vis Sci; 1978 Nov; 17(11):1076-86. PubMed ID: 100468
[TBL] [Abstract][Full Text] [Related]
2. Experimental Pseudomonas keratitis in the rabbit: bacteriologic, clinical, and microscopic observations.
Van Horn DL; Davis SD; Hyndiuk RA; Pederson HJ
Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):213-21. PubMed ID: 6780486
[TBL] [Abstract][Full Text] [Related]
3. The immune system in experimental Pseudomonas keratitis. Model and early effects.
Twining SS; Lohr KM; Moulder JE
Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):507-15. PubMed ID: 3082789
[TBL] [Abstract][Full Text] [Related]
4. [Histologic study of corneal lesions caused by the slime-GLP glycolipoprotein of Pseudomonas aeruginosa].
Pharmakakis N; Papadakis E; Gartaganis S; Bechrakis M; Dimitracopoulos G; Varakis I
Ophtalmologie; 1990; 4(1):72-5. PubMed ID: 2123533
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
[TBL] [Abstract][Full Text] [Related]
6. Experimental Pseudomonas aeruginosa ulcerative keratitis model in the dog.
Wyman M; Swanson C; Kowalski JJ; Powers JD; Boraski EA
Am J Vet Res; 1983 Jun; 44(6):1135-40. PubMed ID: 6870021
[TBL] [Abstract][Full Text] [Related]
7. Bacteriologic cure of experimental Pseudomonas keratitis.
Davis SD; Sarff LD; Hyndiuk RA
Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):916-8. PubMed ID: 100471
[TBL] [Abstract][Full Text] [Related]
8. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of the mouse keratitis produced with Pseudomonas aeruginosa.
Kawaharajo K; Homma JY
Jpn J Exp Med; 1975 Dec; 45(6):515-24. PubMed ID: 822189
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
11. Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage.
Kreger AS; Gray LD
Infect Immun; 1978 Feb; 19(2):630-48. PubMed ID: 415981
[TBL] [Abstract][Full Text] [Related]
12. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
[TBL] [Abstract][Full Text] [Related]
13. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model.
Cole N; Willcox MD; Fleiszig SM; Stapleton F; Bao B; Tout S; Husband A
Curr Eye Res; 1998 Jul; 17(7):730-5. PubMed ID: 9678419
[TBL] [Abstract][Full Text] [Related]
14. Adherence of Pseudomonas aeruginosa to the injured cornea: a step in the pathogenesis of corneal infections.
Ramphal R; McNiece MT; Polack FM
Ann Ophthalmol; 1981 Apr; 13(4):421-5. PubMed ID: 6787968
[TBL] [Abstract][Full Text] [Related]
15. Role of innate and adaptive immunity in the pathogenesis of keratitis.
Hazlett LD
Ocul Immunol Inflamm; 2005; 13(2-3):133-8. PubMed ID: 16019672
[TBL] [Abstract][Full Text] [Related]
16. The role of Pseudomonas aeruginosa elastase in corneal ring abscess formation in pseudomonal keratitis.
Ijiri Y; Yamamoto T; Kamata R; Aoki H; Matsumoto K; Okamura R; Kambara T
Graefes Arch Clin Exp Ophthalmol; 1993 Sep; 231(9):521-8. PubMed ID: 8224956
[TBL] [Abstract][Full Text] [Related]
17. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
[TBL] [Abstract][Full Text] [Related]
18. [The establishment of a rat model of chronic pulmonary infection due to Pseudomonas aeruginosa].
Wang WF; Fang XQ; Liu YN
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):46-50. PubMed ID: 18346380
[TBL] [Abstract][Full Text] [Related]
19. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
Hazlett LD; McClellan S; Kwon B; Barrett R
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
[TBL] [Abstract][Full Text] [Related]
20. Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist.
Esquenazi S; He J; Bazan HE; Bazan NG
J Cataract Refract Surg; 2004 Apr; 30(4):884-91. PubMed ID: 15093656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
